Are circulating adhesion molecules specifically changed in cardiac surgical patients?

Area of Science:

• Cardiovascular Surgery
• Inflammation Markers
• Endothelial Function

Background:

• Soluble adhesion molecules are recognized markers of inflammation, endothelial activation, and damage.
• This study investigated specific alterations in adhesion molecules in patients undergoing cardiac surgery.

Purpose of the Study:

• To assess the impact of cardiac surgical procedures on plasma levels of soluble adhesion molecules.
• To compare these changes with those observed in patients undergoing non-cardiac major surgeries.

Main Methods:

• Prospective study of three patient groups (n=20 each): coronary artery bypass grafting, Whipple pancreatoduodenectomy, and pneumonectomy.
• Measurement of plasma levels of soluble endothelial leukocyte adhesion molecule-1, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and granule membrane protein 140 at multiple time points.

Main Results:

• Cardiac surgery patients showed significant increases in soluble endothelial leukocyte adhesion molecule-1, intercellular adhesion molecule-1, and granule membrane protein 140 post-cardiopulmonary bypass.
• Levels returned to baseline by the first postoperative day, except for soluble vascular cell adhesion molecule-1.
• Patients undergoing Whipple or pneumonectomy procedures exhibited no significant changes in adhesion molecule levels.

Conclusions:

• Cardiac operations are associated with increased plasma levels of soluble adhesion molecules, suggesting endothelial activation or dysfunction.
• In contrast, complex abdominal or lung operations did not alter these markers.
• Proinflammatory cascades, ischemia/reperfusion, and microcirculatory dysfunction are potential explanations for the observed differences.